Nanocarriers for intracellular protein and peptide‐based drug delivery
Tufts University, Massachusetts, United States
This opportunity provides an intracellular lipid‐mediated formulation for protein delivery to cells. This proprietary composition offers a traceless method for intracellular delivery of any protein drug. This new discovery will pave the way for delivery of an emerging class of antibody and protein therapeutics.
Primary Application Area: Biotech & Biological Sciences
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
FIGURES OF MERIT
Value Proposition: Benefits of this technology compared to other liposomal delivery systems include that it is applicable to any protein therapeutic, it utilizes a cost-effective methodology for scalable synthesis of lipids, it provides a traceless delivery method, and it involves broadly-applicable nanocomplexes similar to those already used by companies for RNAi delivery.
Organization Type: Academic/Gov Lab
Showcase Booth #: 637
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date:
Primary Sources of Funding: University
Looking for: Both Funding and Development Partners